Cannabis and Blood Mitochondrial DNA: A Lower Copy Number Is Not a Diagnosis of Injury
Smoked cannabis was followed by a temporary reduction in a whole-blood mitochondrial DNA measure in a controlled study of young adults. That finding does not establish destruction of brain mitochondria, permanent DNA injury or a blood test for cannabis impairment.
What the secondary analysis measured
The parent trial randomized regular cannabis users aged 19–25 to smoke active or placebo cannabis before simulator testing. The active cigarette contained 12.5% THC, and participants smoked to their desired intoxication level within a limited session. Cigarette potency therefore was not a precisely uniform absorbed dose.
After exclusion of mitochondrial-DNA outliers, the analysis included 52 active-treatment and 25 placebo participants. Researchers extracted DNA from frozen whole blood and used quantitative PCR to measure mitochondrial targets relative to a nuclear reference. Repeated blood samples were observations from those participants, not additional independent people.
Positive and null findings belong together
Within the active group, mitochondrial DNA copy number was significantly lower than baseline at 15 minutes and one hour. The placebo group did not show a statistically significant time effect. The paper’s separate within-group analyses should not be mistaken for a direct demonstration of every possible between-group contrast.
Small negative correlations involved 11-hydroxy-THC and THC-COOH, but not parent THC. Associations were more apparent in the subgroup reporting less frequent cannabis use. This pattern raises hypotheses about metabolism and adaptation; it does not show that either metabolite directly caused the change.
Whole blood contains a changing mixture of cells
A central limitation is that the frozen samples could not be used to count the cell types present at each time. Platelets contain mitochondria but no nucleus, whereas white blood cells contain both. A change in their proportions can alter a mitochondrial-to-nuclear DNA measure without demonstrating damage to each cell’s mitochondria.
The experiment also did not directly establish the proposed oxidative-stress mechanism or determine whether the observed change was harmful. The authors specifically identify cell composition and the clinical significance of the finding as unresolved.
Why the specimen limits the inference
This was a human whole-blood biomarker study. It did not sample brain tissue or validate the biomarker against an individual impairment classification. A biological response following exposure is not interchangeable with a measure of functional disability.
For a forensic opinion, ask what was actually measured: copy number, a mutation, cell injury or behavior. Calling all four “DNA damage” would erase the distinctions this study requires.
Related analysis: Concentration Is Not Impairment: THC Blood Levels in California Driving Cases.
Primary research
Pavel Powlowski and colleagues. Acute Cannabis Administration Transiently Reduces Mitochondrial DNA in Young Adults: Findings from a Secondary Analysis of a Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Cannabis and Cannabinoid Research (2024). DOI: 10.1089/can.2023.0282.
